Meanwhile, CRON traded under umbrella of Healthcare sector, the stock was traded -38.13% ahead of its 52-week high and 176.83% beyond its 52-week low. It helps potential investors determine if the firm is using it's invested capital to return profits. The volume added upto 3917152 shares which compares with the average volume of 5.19M shares. Investors may find themselves in the same predicament when markets are heading higher and every stock seems to be a victor. Research and development under this partnership is progressing, and as associated milestones are hit, this new facility is expected to provide Cronos Group with the ability to produce cultured cannabinoids at commercial scale with high-quality and high-purity.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00572, a MACD signal of 0.00318, a MACD difference of 0.00254, a fast Exponential Moving Average (EMA) indicator of 15.025, a slow Exponential Moving Average (EMA) indicator of 15.025, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.01449, a trix of -6.0482, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.05509, a KST Oscillator (KST) of -120.32069 and a KST Oscillator (KST Signal) of -120.32069 (leaving a KST difference of 3.73242). The Relative Strength Index (RSI) is one of multiple popular technical indicators created by J. Welles Wilder.
Watch shares of Cronos Group trade live. They may be still going over all the latest company earnings reports trying to identify some names that can give the portfolio a boost as we move into the New Year. Over the last full year, shares have moved 120.00%. This is calculated by taking the current share price and dividing by the share price one month ago. The company has a consensus rating of "Hold" and an average target price of $19.28. Wall Street analysts have a consensus recommendation of 0on this stock. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating on the company.
We will of course continue to cover the news and price action of Cronos Group Inc., but it's easiest for you to just subscribe to MarketBeat's newsletter above so you don't miss anything. (CRON) we can see that the 30 days volatility is presently 4.32%.
Checking in on some other technical levels, the 14-day RSI is now at 45.23, the 7-day stands at 41.09, and the 3-day is sitting at 41.08. The RSI may be useful for spotting abnormal price activity and volatility.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. The true range indicator is the greatest of the following: current high less the current low, the absolute value of the current high less the previous close and the absolute value of the current low less the previous close. The average true range (ATR) is a technical analysis indicator that measures volatility by decomposing the entire range of an asset price for that period. Three analysts have provided estimates for Cronos Group's earnings, with the lowest EPS estimate coming in at ($0.04) and the highest estimate coming in at ($0.02).
Cross SMA 50/200 = 50 day moving average / 200day moving average.
Cronos Group Inc. (CRON) stock positioned -3.81% distance from the 200-day MA and stock price situated -9.16% away from the 50-day MA while located -9.80% off of the 20-day MA.
RSI value sited with reading of 54.55. (TSX:CRON) is 72. A company with a value of 0 is thought to be an undervalued company, while a company with a value of 100 is considered an overvalued company. It takes a single parameter, the number of time periods to use in the calculation. At the time of writing, the 14-day ADX for Cronos Group Inc (CRON) is 10.60. As of now, CRON has a P/S, P/E and P/B values of 0, 0 and 16.22 respectively. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend. For the next financial year, analysts forecast that the company will post earnings of ($0.04) per share, with EPS estimates ranging from ($0.21) to $0.07. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years.
Investors hope that they won't have to deal with stock picks that don't pan out, but this happens quite often in the stock market.
The EPS of CRON Stock is strolling at -0.03, measuring its EPS growth this year at 0.00%.